Modified host cells for high efficiency production of vanillin

US12480101B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12480101-B2
Application numberUS-202017631429-A
CountryUS
Kind codeB2
Filing dateJul 31, 2020
Priority dateAug 1, 2019
Publication dateNov 25, 2025
Grant dateNov 25, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are genetically modified host cells, compositions, and methods for improved production of vanillin and/or glucovanillin. The host cells, compositions, and methods described herein provide an efficient route for the heterologous production of vanillin and/or glucovanillin and any compound that can be synthesized or biosynthesized from either or both.

First claim

Opening claim text (preview).

What is claimed: 1 . A genetically modified Saccharomyces cerevisiae host cell that produces vanillin or glucovanillin, the host cell comprising: (i) deletion of a homolog of fatty aldehyde dehydrogenase (HFD1) gene; and (ii) one or more nucleic acids expressing: a catechol-O-methyltransferase (COMT); an aromatic carboxylic acid reductase (ACAR) from Nocardia iowensis; a phosphopantetheinyl transferase (PPTASE); and a Podospora pauciseta 3-dehydroshikimate dehydratase (AroZ), wherein the host cell does not express an Hfd1 protein. 2 . The genetically modified Saccharomyces cerevisiae host cell of claim 1 , further comprising deletion of an ADH6 gene. 3 . The genetically modified Saccharomyces cerevisiae host cell of claim 1 , further comprising deletion of a GRE2 gene. 4 . The genetically modified Saccharomyces cerevisiae host cell of claim 1 , further comprising deletion of a YGL039W gene. 5 . The genetically modified Saccharomyces cerevisiae host cell of claim 1 , further comprising one or more nucleic acids expressing a 3-dehydroquinate synthase (AroB) or a dehydroquinate dehydratase (AroD). 6 . The genetically modified Saccharomyces cerevisiae host cell of claim 1 , further comprising one or more nucleic acids expressing an AroB, an AroD, or a phospho-2-dehydro-3-deoxyheptonate aldolase (AroF). 7 . The genetically modified Saccharomyces cerevisiae host cell of claim 1 , further comprising one or more nucleic acids expressing an E. coli AroB, an E. coli AroD, and an E. coli AroF. 8 . The genetically modified Saccharomyces cerevisiae host cell of claim 1 , wherein the PPTASE is a Corynebacterium glutamicum PPTASE. 9 . The genetically modified Saccharomyces cerevisiae host cell of claim 1 , further comprising one or more nucleic acids expressing an eugenol alcohol oxidase (EAO). 10 . The genetically modified Saccharomyces cerevisiae host cell of claim 1 , further comprising one or more nucleic acids expressing a Rhodococcus jostii EAO. 11 . The genetically modified Saccharomyces cerevisiae host cell of claim 1 , further comprising one or more nucleic acids expressing an Arabidopsis thaliana UDP-glycosyltransferase (UGT). 12 . The genetically modified Saccharomyces cerevisiae host cell of claim 1 , wherein the one or more nucleic acids are expressed from an inducible promoter. 13 . The genetically modified Saccharomyces cerevisiae host cell of claim 12 , wherein the inducible promoter is a GAL promoter. 14 . The genetically modified Saccharomyces cerevisiae host cell of claim 12 , wherein the one or more nucleic acids are expressed from a GAL promoter, and wherein the genetically modified Saccharomyces cerevisiae host cell comprises a yeast GAL80 gene expressed from a maltose-responsive promoter. 15 . A method for producing vanillin or glucovanillin, comprising the steps of: a. culturing the genetically modified Saccharomyces cerevisiae host cell of claim 1 in a medium with a carbon source under conditions suitable for making vanillin or glucovanillin; and b. recovering said vanillin or glucovanillin from the medium.

Assignees

Inventors

Classifications

  • Aldehyde dehydrogenase (NAD+) (1.2.1.3) · CPC title

  • containing a carbonyl group · CPC title

  • Vanillin · CPC title

  • having an oxygen atom of the saccharide radical bound to a cyclohexyl radical, e.g. kasugamycin · CPC title

  • Genes encoding for enzymes or proenzymes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12480101B2 cover?
Provided herein are genetically modified host cells, compositions, and methods for improved production of vanillin and/or glucovanillin. The host cells, compositions, and methods described herein provide an efficient route for the heterologous production of vanillin and/or glucovanillin and any compound that can be synthesized or biosynthesized from either or both.
Who is the assignee on this patent?
Amyris Inc
What technology area does this patent fall under?
Primary CPC classification C12N9/0008. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).